Share
Germany-based BioNTech is working with Pfizer Inc. to develop a potential COVID-19 vaccine. The collaboration aims to accelerate the development of BioNTech’s potential COVID-19 mRNA vaccine program, BNT162, which is expected to enter clinical testing by the end of April.
What’s Happening With Your Trial?
At the beginning of 2019, as evidence of the danger of a COVID-19 pandemic was growing, we initiated an internal R&D effort to develop a vaccine to induce immunity and prevent the COVID-19 infection. We named our internal efforts “Project Lightspeed.”
The resulting product candidate, BNT162, is a potential first-in-class mRNA vaccine against COVID-19.
What Are the Next Steps?
The next step in the development process is to initiate clinical testing for BNT162, pending approval from the regulatory agencies, as part of a global clinical development program in Europe, the United States, and China.
We are accelerating operational plans to manufacture the vaccine for clinical trials along with our partner, Polymun, at our state-of-the-art GMP-certified mRNA manufacturing facilities in Europe.
Where Do You See This Going in Coming Months?
We are committed to working as quickly as possible internally and with our partners to advance BTN162 with the goal of saving lives. That means we will continue to follow the regulatory guidelines and rules to ensure a safe and effective vaccine.
We received German regulatory authority approval in 2011 to manufacture mRNA under GMP and have been producing mRNA for clinical testing since then. At this stage, safety is our biggest priority.
As soon as we possibly can, we will provide updates on the development process. It is important to remember that this is not a competitive race. We, together with all companies, research institutes, and governments, represent a global effort to battle a pandemic and save lives.
RELATED TOPICS:
Powell Reiterates Fed Will Wait for More Data Before Cutting Rates
15 minutes ago
Visalia Police Investigate Morning Shooting Outside Bethlehem Center
29 minutes ago
US Senate Republicans Struggling to Unite on Trump’s $3.3 Trillion Tax-Cut Bill
49 minutes ago
Trump Escalates Feud With Musk, Threatens Tesla, SpaceX Support
52 minutes ago
Clovis Police Seek Public’s Help in Finding Missing 82-Year-Old Woman
15 hours ago
Fresno Woman Killed in Head-On Collision, CHP Investigating
16 hours ago
Musk Vows to Punish Lawmakers Who Back Trump’s Spending Bill
17 hours ago
Fresno Man Sentenced to Nearly 6 Years for $4.2 Million Tech Startup Fraud
17 hours ago
Bryan Kohberger Pleads Guilty in Murders of Four Idaho Students, ABC News Reports
17 hours ago
Dollar Gains Ground Against Major Peers After Better-Than-Expected US Jobs Data
5 minutes ago
Categories

Dollar Gains Ground Against Major Peers After Better-Than-Expected US Jobs Data

A Path Forward on Immigration Reform That Strengthens America

France Shuts Schools, Italy Limits Outdoor Work as Heatwave Grips Europe

Powell Reiterates Fed Will Wait for More Data Before Cutting Rates

Visalia Police Investigate Morning Shooting Outside Bethlehem Center

US Senate Republicans Struggling to Unite on Trump’s $3.3 Trillion Tax-Cut Bill
